600062 China Resources Double-Crane Pharmaceutical Co.,Ltd.
Closed 12-23 15:00:00
18.43
-0.07
-0.38%
High18.55Low18.43Vol3.41M
Open18.51D1 Closing18.50Amplitude0.65%
Mkt Cap19.15BTradable Cap19.04BTotal Shares1.04B
T/O63.08MT/O Rate0.33%Tradable Shares1.03B
P/B1.69ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

China Resources Double-Crane's Subsidiary Receives Clinical Trial Approval for DC6001 Tablets
Stock News  ·  12-23 17:03
China Resources Double-Crane's Subsidiary Receives Clinical Trial Approval for DC6001 Tablets
China Resources Double-Crane Pharmaceutical's ADHD Capsules Included in China's Insurance Catalog
MT Newswires Live  ·  12-09
China Resources Double-Crane Pharmaceutical's ADHD Capsules Included in China's Insurance Catalog
China Resources Double-Crane Pharmaceutical (600062.SH): Dexmethylphenidate Hydrochloride Extended-Release Capsules Included in National Reimbursement Drug List
Stock News  ·  12-08
China Resources Double-Crane Pharmaceutical (600062.SH): Dexmethylphenidate Hydrochloride Extended-Release Capsules Included in National Reimbursement Drug List
CR Double-Crane Pharmaceutical Subsidiary Gets Supplementary Approval for Type 2 Diabetes Drug
MT Newswires Live  ·  12-02
CR Double-Crane Pharmaceutical Subsidiary Gets Supplementary Approval for Type 2 Diabetes Drug
China Resources Double-Crane Pharmaceutical (600062.SH) Receives Approval for Pioglitazone Hydrochloride Dispersible Tablets
Stock News  ·  12-01
China Resources Double-Crane Pharmaceutical (600062.SH) Receives Approval for Pioglitazone Hydrochloride Dispersible Tablets
CR Double-Crane Pharma Gets Regulatory Nod for Alternative Hypertension Therapy
MT Newswires Live  ·  11-26
CR Double-Crane Pharma Gets Regulatory Nod for Alternative Hypertension Therapy
China Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets
Stock News  ·  11-25
China Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets
China Approves CR Double-Crane Pharmaceutical Subsidiary's Anti-Seizure Drug
MT Newswires Live  ·  11-19
China Approves CR Double-Crane Pharmaceutical Subsidiary's Anti-Seizure Drug
China Resources Double-Crane Pharmaceutical (600062.SH) Obtains Drug Registration Certificate for Oxcarbazepine Tablets
Stock News  ·  11-18
China Resources Double-Crane Pharmaceutical (600062.SH) Obtains Drug Registration Certificate for Oxcarbazepine Tablets
CR Double-Crane Unit Clears GMP Inspection for Diabetes Drug Line
MT Newswires Live  ·  11-14
CR Double-Crane Unit Clears GMP Inspection for Diabetes Drug Line
China Resources Double-Crane (600062.SH) Subsidiary TIAN AN Passes GMP Compliance Inspection
Stock News  ·  11-13
China Resources Double-Crane (600062.SH) Subsidiary TIAN AN Passes GMP Compliance Inspection
CR Double-Crane Pharma's Q3 Profit Rises 7%, Revenue Slips 3%; Shares Up 1%
MT Newswires Live  ·  10-27
CR Double-Crane Pharma's Q3 Profit Rises 7%, Revenue Slips 3%; Shares Up 1%
BRIEF-China Resources Double-Crane Pharmaceutical Q3 Net Profit Up 6.7% Y/Y
Reuters  ·  10-24
BRIEF-China Resources Double-Crane Pharmaceutical Q3 Net Profit Up 6.7% Y/Y
China Resources Pharmaceutical - 9M Net Profit for China Resources Double-Crane Pharmaceutical RMB1.39 Bln
THOMSON REUTERS  ·  10-24
China Resources Pharmaceutical - 9M Net Profit for China Resources Double-Crane Pharmaceutical RMB1.39 Bln
Shares of "Traditional Chinese Medicine Leader" Pientzehuang Drop 35% from Highs as Q3 Profit Continues to Plummet
Deep News  ·  10-22
Shares of "Traditional Chinese Medicine Leader" Pientzehuang Drop 35% from Highs as Q3 Profit Continues to Plummet
CR Double-Crane Pharmaceutical's Unit Gets Registration Certificate for Alfacalcidol Capsules
MT Newswires Live  ·  10-21
CR Double-Crane Pharmaceutical's Unit Gets Registration Certificate for Alfacalcidol Capsules
China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) Subsidiary Receives Drug Registration Certificate for Alfacalcidol Soft Capsules
Stock News  ·  10-20
China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) Subsidiary Receives Drug Registration Certificate for Alfacalcidol Soft Capsules
CR Double-Crane Pharma's Subsidiary Gets Registration Certificate for Bosentan Dispersible Tablets
MT Newswires Live  ·  09-30
CR Double-Crane Pharma's Subsidiary Gets Registration Certificate for Bosentan Dispersible Tablets
China Resources Double-Crane Pharmaceutical (600062.SH) Subsidiary Receives Drug Registration Certificate for Bosentan Dispersible Tablets
Stock News  ·  09-29
China Resources Double-Crane Pharmaceutical (600062.SH) Subsidiary Receives Drug Registration Certificate for Bosentan Dispersible Tablets
CR Double-Crane Obtains Registration for Cardiac Drug
MT Newswires Live  ·  09-17
CR Double-Crane Obtains Registration for Cardiac Drug

Introduction

Company Name.
华润双鹤药业股份有限公司
Industry:
医药制造业
Listing Date:
1997-05-22
Main Business:
　　华润双鹤药业股份有限公司的主营业务是慢病业务、专科业务和输液业务三大业务。公司的主要产品是输液业务平台、慢病业务平台、专科业务平台、原料药、复方利血平氨苯蝶啶片(0号)、左炔诺孕酮片(金毓婷)、胞磷胆碱钠片(诺百益)、缬沙坦氢氯噻嗪片(复穗悦)、软袋(含直立式)。
Issue price:
6.69